You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pharmacokinetics

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Granulosa-Stromal Tumor, Ovarian Granulosa Cell Tumor, Ovarian Cancer Trial in Canada, Poland, United States

Recruiting
  • Ovarian Granulosa-Stromal Tumor
  • +2 more
  • Los Angeles, California
  • +20 more
Jul 13, 2022

Disease Burden of Diabetic Patients Based on Tianjin Regional

Completed
  • Diabetes
    • Chengdu, China
      Chengdu Big Data Association
    Jul 14, 2022

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL) Trial in Switzerland, United

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • +6 more
    • Tucson, Arizona
    • +23 more
    Dec 14, 2021

    Based on Data From German Sick Funds That Looks at Costs of

    Completed
    • Diabetes Mellitus, Type 2
    • Ingelheim am Rhein, Germany
      Boehringer Ingelheim
    Jan 18, 2022

    Healthy Volunteers Trial in San Antonio (Placebo, teduglutide)

    Completed
    • Healthy Volunteers
    • San Antonio, Texas
      Cetero Clinical Research
    Jun 2, 2021

    Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Abiraterone Acetate, Sodium Selenite, Prednisone)

    Withdrawn
    • Prostate Cancer
    • Castrate Resistant Prostate Cancer
    • Abiraterone Acetate
    • +2 more
    • (no location specified)
    Aug 5, 2021

    Covid19 Trial in United States (sotrovimab)

    Recruiting
    • Covid19
    • sotrovimab
    • Riverside, California
    • +9 more
    Nov 2, 2022

    Healthy Trial (VVZ-149 injection, Placebo)

    Completed
    • Healthy
    • VVZ-149 injection
    • Placebo
    • (no location specified)
    Mar 11, 2019

    Parkinson Disease Trial in Atlanta, Durham (ITI-214, Placebo)

    Completed
    • Parkinson Disease
    • Atlanta, Georgia
    • +1 more
    Dec 18, 2018

    Rheumatoid Arthritis, Giant Cell Arteritis Trial in Australia, India, New Zealand (Tocilizumab Prefilled Syringe)

    Active, not recruiting
    • Rheumatoid Arthritis
    • Giant Cell Arteritis
    • Tocilizumab Prefilled Syringe
    • Brisbane, Australia
    • +3 more
    May 4, 2022

    Advanced Solid Tumor Trial in São Paulo, Santo André (IMX-110 combined with Tislelizumab)

    Recruiting
    • Advanced Solid Tumor
    • IMX-110 combined with Tislelizumab
    • São Paulo, Sao Paulo, Brazil
    • +1 more
    Apr 28, 2023

    NSCLC Trial in Worldwide (RO7247669, Pembrolizumab, Paclitaxel)

    Recruiting
    • Non-small Cell Lung Cancer
    • Benowa, Queensland, Australia
    • +6 more
    Mar 16, 2023

    Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann

    Active, not recruiting
    • Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
    • +11 more
    • Washington, District of Columbia
    • +6 more
    Feb 2, 2023

    Neuroblastoma Trial in Worldwide (LY3295668 Erbumine, Topotecan, Cyclophosphamide)

    Active, not recruiting
    • Neuroblastoma
    • LY3295668 Erbumine
    • +2 more
    • San Francisco, California
    • +21 more
    Aug 17, 2022

    Severe Sepsis Trial in United States (Nivolumab)

    Completed
    Has Results
    • Severe Sepsis
    • Nivolumab
    • Sacramento, California
    • +15 more
    Apr 19, 2019

    Food Effect, Health Subjects Trial in Shanghai (Volitinib)

    Completed
    • Food Effect
    • Health Subjects
    • Shanghai, Shanghai, China
      Shanghai Xuhui Central Hospital
    May 12, 2019

    Pharmacokinetics of ASP9853, Non-hematologic Malignancies Trial in Boston, Detroit, Nashville (ASP9853, Docetaxel, Paclitaxel)

    Terminated
    • Pharmacokinetics of ASP9853
    • Non-hematologic Malignancies
    • Boston, Massachusetts
    • +3 more
    May 29, 2019

    Advanced Solid Tumor Trial in Beijing (Simmitinib)

    Recruiting
    • Advanced Solid Tumor
    • Beijing, China
      CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
    Jun 2, 2022

    MDD Trial in Dallas (LY2216684, Theophylline)

    Completed
    Has Results
    • Major Depressive Disorder
    • Dallas, Texas
      For additional information regarding investigative sites for thi
    Apr 16, 2019

    Leukemia, Myeloid, Acute Trial in Poznan (Liposomal Annamycin, Cytarabine)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Bologna, Italy
    • +4 more
    Jan 31, 2023

    Solid Tumors Trial in Worldwide (Avelumab)

    Completed
    Has Results
    • Solid Tumors
    • Goodyear, Arizona
    • +73 more
    Oct 26, 2021

    Pediatric Cancer, Solid Tumor Pediatric, Hematological Malignancies Trial in Worldwide (Durvalumab / Tremelimumab Combination

    Active, not recruiting
    • Pediatric Cancer
    • +2 more
    • Durvalumab / Tremelimumab Combination Therapy
    • Baltimore, Maryland
    • +18 more
    Nov 3, 2022

    Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Tumor Trial in New Brunswick

    Active, not recruiting
    • Ann Arbor Stage III Non-Hodgkin Lymphoma
    • +2 more
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Jan 28, 2023

    Methylprednisone Administration, Intranasal Administration, Intravenous Administration Trial in Mexico City (Evaluation of

    Completed
    • Methylprednisone Administration
    • +3 more
    • Evaluation of bioavailability of methylprednisolone succinate administered intravenously
    • Evaluation of bioavailability of methylprednisolone succinate administered intranasally
    • Mexico City, Mexico
      Universidad Nacional Autonoma de Mexico
    Dec 13, 2022

    Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)

    Completed
    • Hepatitis C
    • Peginterferon alfa-2a
    • +2 more
    • Rotterdam, Netherlands
      Erasmus Medical Center
    Aug 26, 2021